MétaCan
Menu
← Back to cohort

Clinico-pathologic and molecular characteristics of patients with resected lung adenocarcinoma.

2016· article· en· W2890074783 on OpenAlexaff
Mihaela Mates, Shuo Xu, Alexander H. Boag, Wilma M. Hopman, Harriet Feilotter

Bibliographic record

VenueJournal of Clinical Oncology · 2016
Typearticle
Languageen
FieldMedicine
TopicLung Cancer Treatments and Mutations
Canadian institutionsQueen's University
Fundersnot available
KeywordsKRASMedicineAdenocarcinomaMalignancyStage (stratigraphy)Internal medicineLung cancerMolecular pathologyLungOncologyAdjuvant therapyPathologyCancerGastroenterologyColorectal cancerGeneBiology

Abstract

fetched live from OpenAlex

e23134 Background: Lung adenocarcinoma (LA) is the most common lung malignancy. Recently, a novel histologic classification was recognized as a stage-independent predictor of survival. Furthermore, important molecular discoveries in the lung cancer genome have identified targetable driver mutations that led to new therapeutic interventions. The purpose of this study was to assess clinico-pathologic and molecular characteristics of patients with resected LA at our centre. Methods: Through pathology records we identified patients with resected LA between January 2005 - December 2008. We collected demographic, treatment, pathologic tumor characteristics and disease outcomes. Molecular analysis was undertaken to investigate genomic profile by next generation sequencing assays (NGS). Data were analyzed to determine associations between clinico-pathologic and molecular characteristics and disease outcomes (chi-square tests, independent samples t-tests and Mann-Whitney U). Results: We identified 121 eligible patients. Mean age: 65; 58% female; 7% nonsmokers; 81% lobectomy. Stage distribution: I – 64%, II – 20%, III – 16%. Histologic subtype: mucinous 9%; lepidic 11%; acinar 46%; solid 27%; micro/papillary 7%. Neo/adjuvant therapy – 35%. Of these patients we obtained DNA and RNA from 36 tumors and molecular analysis was successful on all samples. Genomic alterations results: KRAS – 55%; EGFR – 11%; p53 – 51%; MET 8%; RET – 6%; HER 2 – 3% BRAF – 3%; ALK and ROS – 0%. Five-year overall survival (OS) was 69%; by stage: I – 79%; II – 37%; III – 65%; by neo/adjuvant therapy (yes vs no): stage I – 85 vs 78%; II – 41 vs 29%; III – 50 vs 87%; by histologic subtype: mucinous – 82%; lepidic – 92%; acinar – 70%; solid/micro/papillary – 56%; by KRAS status: wild-type 75%, mutated 74%. Conclusions: In this predominantly smoking population with resected LA the most common histologic subtype was acinar; the proportion of KRAS-mutations was higher than the national average, and the incidence of RET rearrangements was higher than expected. In this small study significant OS benefit with neo/adjuvant therapy was seen in stage I and II LA but not stage III; no significant associations were found between histological subtypes and KRAS mutation status.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.047
GPT teacher head0.449
Teacher spread0.402 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicLung Cancer Treatments and Mutations→French-language works237,207→